• +1-646-491-9876
    • +91-20-67278686

    Search

    Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H1 2017

    Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H1 2017

    • Report Code ID: RW0001709445
    • Category Pharmaceuticals
    • No. of Pages 43
    • Publication Month Mar-17
    • Publisher Name Global Markets Direct
    Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H1 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Lassa Fever - Pipeline Review, H1 2017, provides an overview of the Lassa Fever (Infectious Disease) pipeline landscape.

    Lassa fever is an acute viral hemorrhagic illness caused by Lassa virus, a member of the arenavirus family of viruses. It is transmitted to humans from contacts with food or household items contaminated with rodent excreta. Symptoms include fever, headache, chills, back pain, weight loss, swollen neck, rashes and bleeding.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Lassa Fever - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Lassa Fever (Infectious Disease) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Lassa Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lassa Fever (Lassa Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Preclinical and Discovery stages are 9 and 4 respectively.

    Lassa Fever (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Lassa Fever (Infectious Disease) .
    - The pipeline guide reviews pipeline therapeutics for Lassa Fever (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Lassa Fever (Infectious Disease) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Lassa Fever (Infectious Disease) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Lassa Fever (Infectious Disease)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Lassa Fever (Infectious Disease) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Lassa Fever (Infectious Disease) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    List of Tables
    List of Figures
    Introduction
    Publisher Report Coverage
    Lassa Fever (Lassa Hemorrhagic Fever) - Overview
    Lassa Fever (Lassa Hemorrhagic Fever) - Therapeutics Development
    Pipeline Overview
    Pipeline by Companies
    Products under Development by Companies
    Lassa Fever (Lassa Hemorrhagic Fever) - Therapeutics Assessment
    Assessment by Target
    Assessment by Mechanism of Action
    Assessment by Route of Administration
    Assessment by Molecule Type
    Lassa Fever (Lassa Hemorrhagic Fever) - Companies Involved in Therapeutics Development
    Arno Therapeutics Inc
    Celgene Corp
    Etubics Corp
    Fab'entech SA
    Kineta Inc
    Profectus BioSciences Inc
    SIGA Technologies Inc
    Lassa Fever (Lassa Hemorrhagic Fever) - Drug Profiles
    AR-12 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    CC-11050 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    FBH-003 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    KIN-1400 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    lassa fever vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    lassa fever vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    lassa fever vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    LHF-535 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    ML-29 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Monoclonal Antibodies for Lassa Fever - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Small Molecules for Lassa Fever - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Small Molecules to Inhibit NPC1 for Ebola and Lassa Fever Virus - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    ST-193 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Lassa Fever (Lassa Hemorrhagic Fever) - Dormant Projects
    Lassa Fever (Lassa Hemorrhagic Fever) - Product Development Milestones
    Featured News & Press Releases
    May 05, 2016: Kineta Receives Wellcome Trust Award to Advance Novel Therapeutic for Lassa Fever into Clinical Trials
    Apr 22, 2016: Kineta Presents Promising New Data on Novel Lassa Fever Antiviral and Broad Spectrum Innate Immune Antivirals
    May 28, 2015: Arno Therapeutics Announces AR-12 Antiviral Data Against Multiple Hemorrhagic Fevers Published Online in Antiviral Research
    Appendix
    Methodology
    Coverage
    Secondary Research
    Primary Research
    Expert Panel Validation
    Contact Us
    Disclaimer

    List of Tables

    Number of Products under Development for Lassa Fever (Lassa Hemorrhagic Fever) , H1 2017
    Number of Products under Development by Companies, H1 2017
    Products under Development by Companies, H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Arno Therapeutics Inc, H1 2017
    Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Celgene Corp, H1 2017
    Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Etubics Corp, H1 2017
    Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Fab'entech SA, H1 2017
    Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Kineta Inc, H1 2017
    Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Profectus BioSciences Inc, H1 2017
    Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by SIGA Technologies Inc, H1 2017
    Lassa Fever (Lassa Hemorrhagic Fever) - Dormant Projects, H1 2017

    List of Figures

    Number of Products under Development for Lassa Fever (Lassa Hemorrhagic Fever) , H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products by Targets, H1 2017
    Number of Products by Stage and Targets, H1 2017
    Number of Products by Mechanism of Actions, H1 2017
    Number of Products by Stage and Mechanism of Actions, H1 2017
    Number of Products by Routes of Administration, H1 2017
    Number of Products by Stage and Routes of Administration, H1 2017
    Number of Products by Molecule Types, H1 2017
    Number of Products by Stage and Molecule Types, H1 2017
    Arno Therapeutics Inc
    Celgene Corp
    Etubics Corp
    Fab'entech SA
    Kineta Inc
    Profectus BioSciences Inc
    SIGA Technologies Inc

    Request for Sample

    Report Url http://www.reportsweb.com//lassa-fever-lassa-hemorrhagic-fever-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//lassa-fever-lassa-hemorrhagic-fever-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//lassa-fever-lassa-hemorrhagic-fever-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments